1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6B4011DE5C87D7BBB85256E4B006920AC
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/global-trends-in-e-detailing?opendocument
18
19opendocument
2034.228.38.35
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Sales and Marketing Sales Management Enhancing Selling Effectiveness Planning and Targeting Detailing

Global Trends in E-detailing

DB Image

ID: 4574


Features:

Metrics, Graphics, Summary Matrix


Pages/Slides: 17


Published: Pre-2013


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Study Overview

Based on a survey of nine pharmaceutical organizations, this 17-slide presentation measures the type and prevalence of e-detailing activities and programs in Europe, Asia and the United States. Key topic areas in this study include: prevalence of e-detailing activities used, types of incentives provided, effective targeting of e-detailing activities and e-detailing budgets. Companies can use this information to understand the application and success of e-detailing programs around the world.

Key Findings
The study found that web-based and email-based activities are the most popular forms of e-detailing. Most executives reported that e-detailing comprises less than 10% of their promotional budgets. In addition, most executives measure the success of e-detailing programs by the number of physicians reached and the number of prescriptions generated.

Methodology
This information was collected from Best Practices, LLC Internet Benchmarking Exchange service.


Industries Profiled:
Pharmaceutical; Biotech; Health Care


Companies Profiled:
AstraZeneca; Axcan Pharma; Janssen Cilag Pharmaceutical; Datapharm; Organon; Lilly; Pfizer; Ranbaxy; Schering-Plough


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.